Table II.
MSRB3 expression | ||||
---|---|---|---|---|
Variable | Cases, n | Low | High | P-value |
Age, years | 0.731 | |||
<65 | 39 | 12 | 27 | |
≥65 | 51 | 14 | 37 | |
Sex | 0.901 | |||
Female | 20 | 6 | 14 | |
Male | 70 | 20 | 50 | |
Maximum tumor diameter, cm | 0.850 | |||
<5 | 30 | 9 | 21 | |
≥5 | 57 | 16 | 41 | |
Histological differentiation | 0.972 | |||
Moderate-high | 24 | 7 | 17 | |
Poor | 66 | 19 | 47 | |
Depth of invasion | 0.403 | |||
T1-2 | 11 | 2 | 9 | |
T3-4 | 79 | 24 | 55 | |
Lymph node metastasis | 0.850 | |||
N0 | 23 | 7 | 16 | |
N+ | 67 | 19 | 48 | |
Distant metastasis | 0.697 | |||
M0 | 86 | 24 | 62 | |
M1 | 4 | 2 | 2 | |
TNM stage | 0.745 | |||
I/II | 37 | 10 | 27 | |
III/IV | 53 | 16 | 37 |
MSRB3, methionine sulfoxide reductases B3; TNM, Tumor-Node-Metastasis; GC, gastric cancer.